Beyond symptomatic improvement: Assessing real-world outcomes in patients with major depressive disorder

Primary Care Companion to the Journal of Clinical Psychiatry

Volumn 12, Issue 2, 2010, Pages

  Langlieb, Alan M ^a   Guico Pabia, Christine J ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

ARTICLE; DISEASE ASSOCIATION; FAMILY FUNCTIONING; FUNCTIONAL ASSESSMENT; HEALTH CARE COST; HUMAN; MAJOR DEPRESSION; PHYSICAL DISABILITY; PSYCHOTHERAPY; QUALITY OF LIFE; SHEEHAN DISABILITY SCALE; SHORT FORM 36; SOCIAL PSYCHOLOGY; SYMPTOMATOLOGY; WORK DISABILITY; WORK LIMITATIONS QUESTIONNAIRE;

EID: 78650578067     PISSN: 15235998     EISSN: 1555211X     Source Type: Journal    
DOI: 10.4088/PCC.09r00826blu     Document Type: Article

References (128)

1. Kessler RC, Berglund P, Demler O, et al. National Comorbidity Survey Replication. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289(23):3095-3105. PubMed doi:10.1001/jama.289.23.3095
2. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet. 1997;349(9063):1436-1442. PubMed doi:10.1016/S0140-6736(96)07495-8
3. World Health Organization. The World Health Report: 2001-Mental Health: New Understanding, New Hope. Geneva, Switzerland: World Health Organization; 2001.
4. Thrall G, Lane D, Carroll D, et al. Quality of life in patients with atrial fibrillation: a systematic review. Am J Med. 2006;119(5):448-519, e1-e19. PubMed doi:10.1016/j.amjmed.2005.10.057
5. Williams RG, Pearson GD, Barst RJ, et al. Report of the National Heart, Lung, and Blood Institute Working Group on research in adult congenital heart disease. J Am Coll Cardiol. 2006;47(4):701-707. PubMed doi:10.1016/j.jacc.2005.08.074
6. Huang IC, Hwang CC, Wu MY, et al. Diabetes-specific or generic measures for health-related quality of life? evidence from psychometric validation of the D-39 and SF-36. Value Health. 2008;11(3):450-461. PubMed doi:10.1111/j.1524-4733.2007.00261.x
7. Greenberg PE, Kessler RC, Birnbaum HG, et al. The economic burden of depression in the United States: how did it change between 1990 and 2000? J Clin Psychiatry. 2003;64(12):1465-1475. PubMed
8. Birnbaum HG, Leong SA, Greenberg PE. The economics of women and depression: an employer's perspective. J Affect Disord. 2003;74(1):15-22. PubMed doi:10.1016/S0165-0327(02)00427-5
9. Kessler RC, Akiskal HS, Ames M, et al. Prevalence and effects of mood disorders on work performance in a nationally representative sample of US workers. Am J Psychiatry. 2006;163(9):1561-1568. PubMed doi:10.1176/appi.ajp.163.9.1561
10. Druss BG, Rosenheck RA, Sledge WH. Health and disability costs of depressive illness in a major US corporation. Am J Psychiatry. 2000;157(8):1274-1278. PubMed doi:10.1176/appi.ajp.157.8.1274
11. Gameroff MJ, Olfson M. Major depressive disorder, somatic pain, and health care costs in an urban primary care practice. J Clin Psychiatry. 2006;67(8):1232-1239. PubMed
12. Emptage NP, Sturm R, Robinson RL. Depression and comorbid pain as predictors of disability, employment, insurance status, and health care costs. Psychiatr Serv. 2005;56(4):468-474. PubMed doi:10.1176/appi.ps.56.4.468
13. Katon WJ, Lin E, Russo J, et al. Increased medical costs of a population-based sample of depressed elderly patients. Arch Gen Psychiatry. 2003;60(9):897-903. PubMed doi:10.1001/archpsyc.60.9.897
14. Simon GE, Katon WJ, Lin EH, et al. Diabetes complications and depression as predictors of health service costs. Gen Hosp Psychiatry. 2005;27(5):344-351. PubMed doi:10.1016/j.genhosppsych.2005.04.008
15. Katon WJ, Rutter C, Simon G, et al. The association of comorbid depression with mortality in patients with type 2 diabetes. Diabetes Care. 2005;28(11):2668-2672. PubMed doi:10.2337/diacare.28.11.2668
16. Barefoot JC, Helms MJ, Mark DB, et al. Depression and long-term mortality risk in patients with coronary artery disease. Am J Cardiol. 1996;78(6):613-617. PubMed doi:10.1016/S0002-9149(96)00380-3
17. Kaufmann MW, Fitzgibbons JP, Sussman EJ, et al. Relation between myocardial infarction, depression, hostility, and death. Am Heart J. 1999;138(3, pt 1):549-554. PubMed doi:10.1016/S0002-8703(99)70159-6
18. Wittchen HU, Carter RM, Pfister H, et al. Disabilities and quality of life in pure and comorbid generalized anxiety disorder and major depression in a national survey. Int Clin Psychopharmacol. 2000;15(6):319-328. PubMed doi:10.1097/00004850-200015060-00002
19. Holmes AJ, Pizzagalli DA. Spatiotemporal dynamics of error processing dysfunctions in major depressive disorder. Arch Gen Psychiatry. 2008;65(2):179-188. PubMed doi:10.1001/archgenpsychiatry.2007.19
20. Mondal S, Sharma VK, Das S, et al. Neuro-cognitive functions in patients of major depression. Indian J Physiol Pharmacol. 2007;51(1):69-75. PubMed
21. Smith DJ, Muir WJ, Blackwood DH. Neurocognitive impairment in euthymic young adults with bipolar spectrum disorder and recurrent major depressive disorder. Bipolar Disord. 2006;8(1):40-46. PubMed doi:10.1111/j.1399-5618.2006.00275.x
22. Wang PS, Beck AL, Berglund P, et al. Effects of major depression on moment-in-time work performance. Am J Psychiatry. 2004;161(10):1885-1891. PubMed doi:10.1176/appi.ajp.161.10.1885
23. Lerner D, Adler DA, Chang H, et al. Unemployment, job retention, and productivity loss among employees with depression. Psychiatr Serv. 2004;55(12):1371-1378. PubMed doi:10.1176/appi.ps.55.12.1371
24. Marcotte DE, Wilcox-Gök V, Redmon PD. Prevalence and patterns of major depressive disorder in the United States labor force. J Ment Health Policy Econ. 1999;2(3):123-131. PubMed doi:10.1002/(SICI)1099-176X(199909)2:3<123::AID-MHP55>3.0.CO;2-8
25. Adler DA, McLaughlin TJ, Rogers WH, et al. Job performance deficits due to depression. Am J Psychiatry. 2006;163(9):1569-1576. PubMed doi:10.1176/appi.ajp.163.9.1569
26. Berndt ER, Finkelstein SN, Greenberg PE, et al. Workplace performance effects from chronic depression and its treatment. J Health Econ. 1998;17(5):511-535. PubMed doi:10.1016/S0167-6296(97)00043-X
27. Druss BG, Schlesinger M, Allen HM Jr. Depressive symptoms, satisfaction with health care, and 2-year work outcomes in an employed population. Am J Psychiatry. 2001;158(5):731-734. PubMed doi:10.1176/appi.ajp.158.5.731
28. Stewart WF, Ricci JA, Chee E, et al. Cost of lost productive work time among US workers with depression. JAMA. 2003;289(23):3135-3144. PubMed doi:10.1001/jama.289.23.3135
29. Mojtabai R. Residual symptoms and impairment in major depression in the community. Am J Psychiatry. 2001;158(10):1645-1651. PubMed doi:10.1176/appi.ajp.158.10.1645
30. Wells KB, Stewart A, Hays RD, et al. The functioning and well-being of depressed patients: results from the Medical Outcomes Study. JAMA. 1989;262(7):914-919. PubMed doi:10.1001/jama.262.7.914
31. Backenstrass M, Frank A, Joest K, et al. A comparative study of nonspecific depressive symptoms and minor depression regarding functional impairment and associated characteristics in primary care. Compr Psychiatry. 2006;47(1):35-41. PubMed doi:10.1016/j.comppsych.2005.04.007
32. Cuijpers P, de Graaf R, van Dorsselaer S. Minor depression: risk profiles, functional disability, health care use and risk of developing major depression. J Affect Disord. 2004;79(1-3):71-79. PubMed doi:10.1016/S0165-0327(02)00348-8
33. Wagner HR, Burns BJ, Broadhead WE, et al. Minor depression in family practice: functional morbidity, co-morbidity, service utilization and outcomes. Psychol Med. 2000;30(6):1377-1390. PubMed doi:10.1017/S0033291799002998
34. Adler DA, Irish J, McLaughlin TJ, et al. The work impact of dysthymia in a primary care population. Gen Hosp Psychiatry. 2004;26(4):269-276. PubMed doi:10.1016/j.genhosppsych.2004.04.004
35. Spitzer RL, Kroenke K, Linzer M, et al. Health-related quality of life in primary care patients with mental disorders: results from the PRIME-MD 1000 Study. JAMA. 1995;274(19):1511-1517. PubMed doi:10.1001/jama.274.19.1511
36. Saarijärvi S, Salminen JK, Toikka T, et al. Health-related quality of life among patients with major depression. Nord J Psychiatry. 2002;56(4):261-264. PubMed doi:10.1080/08039480260242741
37. Judd LL, Akiskal HS, Zeller PJ, et al. Psychosocial disability during the long-term course of unipolar major depressive disorder. Arch Gen Psychiatry. 2000;57(4):375-380. PubMed doi:10.1001/archpsyc.57.4.375
38. Judd LL, Schettler PJ, Solomon DA, et al. Psychosocial disability and work role function compared across the long-term course of bipolar I, bipolar II and unipolar major depressive disorders. J Affect Disord. 2008;108(1-2):49-58. PubMed doi:10.1016/j.jad.2007.06.014
39. Cronin-Stubbs D, de Leon CF, Beckett LA, et al. Six-year effect of depressive symptoms on the course of physical disability in community-living older adults. Arch Intern Med. 2000;160(20):3074-3080. PubMed doi:10.1001/archinte.160.20.3074
40. Katon W, Lin EH, Kroenke K. The association of depression and anxiety with medical symptom burden in patients with chronic medical illness. Gen Hosp Psychiatry. 2007;29(2):147-155. PubMed doi:10.1016/j.genhosppsych.2006.11.005
41. Stein MB, Cox BJ, Afifi TO, et al. Does co-morbid depressive illness magnify the impact of chronic physical illness? a population-based perspective. Psychol Med. 2006;36(5):587-596. PubMed doi:10.1017/S0033291706007239
42. Strine TW, Chapman DP, Kobau R, et al. Depression, anxiety, and physical impairments and quality of life in the US noninstitutionalized population. Psychiatr Serv. 2004;55(12):1408-1413. PubMed doi:10.1176/appi.ps.55.12.1408
43. Trivedi MH, Rush AJ, Wisniewski SR, et al. Factors associated with health-related quality of life among outpatients with major depressive disorder: a STAR*D report. J Clin Psychiatry. 2006;67(2):185-195. PubMed
44. Baune BT, Adrian I, Jacobi F. Medical disorders affect health outcome and general functioning depending on comorbid major depression in the general population. J Psychosom Res. 2007;62(2):109-118. PubMed doi:10.1016/j.jpsychores.2006.09.014
45. Beekman AT, Penninx BW, Deeg DJ, et al. The impact of depression on the well-being, disability and use of services in older adults: a longitudinal perspective. Acta Psychiatr Scand. 2002;105(1):20-27. PubMed doi:10.1034/j.1600-0447.2002.10078.x
46. Dorenlot P, Harboun M, Bige V, et al. Major depression as a risk factor for early institutionalization of dementia patients living in the community. Int J Geriatr Psychiatry. 2005;20(5):471-478. PubMed doi:10.1002/gps.1238
47. Egede LE. Major depression in individuals with chronic medical disorders: prevalence, correlates and association with health resource utilization, lost productivity and functional disability. Gen Hosp Psychiatry. 2007;29(5):409-416. PubMed doi:10.1016/j.genhosppsych.2007.06.002
48. Papapetropoulos S, Ellul J, Argyriou AA, et al. The effect of depression on motor function and disease severity of Parkinson's disease. Clin Neurol Neurosurg. 2006;108(5):465-469. PubMed doi:10.1016/j.clineuro.2005.08.002
49. Simon GE, Revicki D, Heiligenstein J, et al. Recovery from depression, work productivity, and health care costs among primary care patients. Gen Hosp Psychiatry. 2000;22(3):153-162. PubMed doi:10.1016/S0163-8343(00)00072-4
50. Angermeyer MC, Holzinger A, Matschinger H, et al. Depression and quality of life: results of a follow-up study. Int J Soc Psychiatry. 2002;48(3):189-199. PubMed doi:10.1177/002076402128783235
51. Dombrovski AY, Lenze EJ, Dew MA, et al. Maintenance treatment for old-age depression preserves health-related quality of life: a randomized, controlled trial of paroxetine and interpersonal psychotherapy. J Am Geriatr Soc. 2007;55(9):1325-1332. PubMed doi:10.1111/j.1532-5415.2007.01292.x
52. Keller MB, Trivedi MH, Thase ME, et al. The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) study: outcomes from the 2-year and combined maintenance phases. J Clin Psychiatry. 2007;68(8):1246-1256. PubMed doi:10.4088/JCP.v68n0812
53. Trivedi MH, Rush AJ, Wisniewski SR, et al. STAR*D Study Team. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry. 2006;163(1):28-40. PubMed doi:10.1176/appi.ajp.163.1.28
54. Wang PS, Patrick A, Avorn J, et al. The costs and benefits of enhanced depression care to employers. Arch Gen Psychiatry. 2006;63(12):1345-1353. PubMed doi:10.1001/archpsyc.63.12.1345
55. Wang PS, Simon GE, Avorn J, et al. Telephone screening, outreach, and care management for depressed workers and impact on clinical and work productivity outcomes: a randomized controlled trial. JAMA. 2007;298(12):1401-1411. PubMed doi:10.1001/jama.298.12.1401
56. Zhang M, Rost KM, Fortney JC. Earnings changes for depressed individuals treated by mental health specialists. Am J Psychiatry. 1999;156(1):108-114. PubMed
57. Goldman W, McCulloch J, Cuffel B, et al. Outpatient utilization patterns of integrated and split psychotherapy and pharmacotherapy for depression. Psychiatr Serv. 1998;49(4):477-482. PubMed
58. Hankin JR, Kessler LG, Goldberg ID, et al. A longitudinal study of offset in the use of nonpsychiatric services following specialized mental health care. Med Care. 1983;21(11):1099-1110. PubMed doi:10.1097/00005650-198311000-00006
59. Leon AC, Walkup JT, Portera L. Assessment and treatment of depression in disability claimants: a cost-benefit simulation study. J Nerv Ment Dis. 2002;190(1):3-9. PubMed doi:10.1097/00005053-200201000-00002
60. Von Korff M, Katon W, Bush T, et al. Treatment costs, cost offset, and cost-effectiveness of collaborative management of depression. Psychosom Med. 1998;60(2):143-149. PubMed
61. Von Korff M, Katon W, Rutter C, et al. Effect on disability outcomes of a depression relapse prevention program. Psychosom Med. 2003;65(6):938-943. PubMed doi:10.1097/01.PSY.0000097336.95046.0C
62. Araya R, Flynn T, Rojas G, et al. Cost-effectiveness of a primary care treatment program for depression in low-income women in Santiago, Chile. Am J Psychiatry. 2006;163(8):1379-1387. PubMed doi:10.1176/appi.ajp.163.8.1379
63. Aziz M, Mehringer AM, Mozurkewich E, et al. Cost-utility of 2 maintenance treatments for older adults with depression who responded to a course of electroconvulsive therapy: results from a decision analytic model. Can J Psychiatry. 2005;50(7):389-397. PubMed
64. Mitchell J, Greenberg J, Finch K, et al. Effectiveness and economic impact of antidepressant medications: a review. Am J Manag Care. 1997;3(2):323-330, quiz 331. PubMed
65. von Knorring L, Akerblad AC, Bengtsson F, et al. Cost of depression: effect of adherence and treatment response. Eur Psychiatry. 2006;21(6):349-354. PubMed doi:10.1016/j.eurpsy.2006.04.005
66. Berlim MT, Pargendler J, Brenner J, et al. Significant improvement in the quality of life of Brazilian depressed outpatients 12 weeks following the start of antidepressants. Psychiatry Res. 2007;153(3):253-259. PubMed doi:10.1016/j.psychres.2006.07.006
67. Vos T, Haby MM, Barendregt JJ, et al. The burden of major depression avoidable by longer-term treatment strategies. Arch Gen Psychiatry. 2004;61(11):1097-1103. PubMed doi:10.1001/archpsyc.61.11.1097
68. Claxton AJ, Chawla AJ, Kennedy S. Absenteeism among employees treated for depression. J Occup Environ Med. 1999;41(7):605-611. PubMed doi:10.1097/00043764-199907000-00009
69. Dewa CS, Hoch JS, Lin E, et al. Pattern of antidepressant use and duration of depression-related absence from work. Br J Psychiatry. 2003;183(6):507-513. PubMed doi:10.1192/bjp.183.6.507
70. Rizzo JA, Abbott TA 3rd, Pashko S. Labour productivity effects of prescribed medicines for chronically ill workers. Health Econ. 1996;5(3):249-265. PubMed doi:10.1002/(SICI)1099-1050(199605)5:3<249::AID-HEC203>3.0.CO;2-A
71. Trivedi MH, Fava M, Wisniewski SR, et al. STAR*D Study Team. Medication augmentation after the failure of SSRIs for depression. N Engl J Med. 2006;354(12):1243-1252. PubMed doi:10.1056/NEJMoa052964
72. Honkonen TI, Aro TA, Isometsä ET, et al. Quality of treatment and disability compensation in depression: comparison of 2 nationally representative samples with a 10-year interval in Finland. J Clin Psychiatry. 2007;68(12):1886-1893. PubMed doi:10.4088/JCP.v68n1208
73. Lo Sasso AT, Rost K, Beck A. Modeling the impact of enhanced depression treatment on workplace functioning and costs: a cost-benefit approach. Med Care. 2006;44(4):352-358. PubMed doi:10.1097/01.mlr.0000204049.30620.1e
74. Lo Sasso AT, Lindrooth RC, Lurie IZ, et al. Expanded mental health benefits and outpatient depression treatment intensity. Med Care. 2006;44(4):366-372. PubMed doi:10.1097/01.mlr.0000204083.55544.f8
75. Bagby RM, Ryder AG, Cristi C. Psychosocial and clinical predictors of response to pharmacotherapy for depression. J Psychiatry Neurosci. 2002;27(4):250-257. PubMed
76. Lenze EJ, Miller MD, Dew MA, et al. Subjective health measures and acute treatment outcomes in geriatric depression. Int J Geriatr Psychiatry. 2001;16(12):1149-1155. PubMed doi:10.1002/gps.503
77. Solomon DA, Leon AC, Endicott J, et al. Psychosocial impairment and recurrence of major depression. Compr Psychiatry. 2004;45(6):423-430. PubMed doi:10.1016/j.comppsych.2004.07.002
78. Solomon DA, Leon AC, Coryell W, et al. Predicting recovery from episodes of major depression. J Affect Disord. 2008;107(1-3):285-291. PubMed doi:10.1016/j.jad.2007.09.001
79. Sotsky SM, Glass DR, Shea MT, et al. Patient predictors of response to psychotherapy and pharmacotherapy: findings in the NIMH Treatment of Depression Collaborative Research Program. Am J Psychiatry. 1991;148(8):997-1008. PubMed
80. Aaronson NK, Muller M, Cohen PD, et al. Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol. 1998;51(11):1055-1068. PubMed doi:10.1016/S0895-4356(98)00097-3
81. Ware JE Jr, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36), I: conceptual framework and item selection. Med Care. 1992;30(6):473-483. PubMed doi:10.1097/00005650-199206000-00002
82. Sheehan DV. Sheehan Disability Scale. In: Rush AJ, Pincus HA, First MB, et al, eds. Handbook of Psychiatric Measures. 1st ed. Washington, DC: American Psychiatric Association; 2000:113-115.
83. Lerner D, Amick BC 3rd, Rogers WH, et al. The Work Limitations Questionnaire. Med Care. 2001;39(1):72-85. PubMed doi:10.1097/00005650-200101000-00009
84. World Health Organization. Wellbeing Measures in Primary Health Care/the Depcare Project. Copenhagen, Denmark: WHO Regional Office for Europe; 1998.
85. Weissman MM, Bothwell S. Assessment of social adjustment by patient self-report. Arch Gen Psychiatry. 1976;33(9):1111-1115. PubMed
86. Endicott J, Nee J, Harrison W, et al. Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacol Bull. 1993;29(2):321-326. PubMed
87. Endicott J, Nee J. Endicott Work Productivity Scale (EWPS): a new measure to assess treatment effects. Psychopharmacol Bull. 1997;33(1):13-16. PubMed
88. Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993;4(5):353-365. PubMed doi:10.2165/00019053-199304050-00006
89. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994.
90. Bech P, Lunde M, Undén M. Social Adaptation Self-evaluation Scale (SASS): psychometric analysis as outcome measure in the treatment of patients with major depression in the remission phase. Int J Psychiatry Clin Pract. 2002;6:141-146. doi:10.1080/136515002760276063
91. Hirschfeld RM, Dunner DL, Keitner G, et al. Does psychosocial functioning improve independent of depressive symptoms? a comparison of nefazodone, psychotherapy, and their combination. Biol Psychiatry. 2002;51(2):123-133. PubMed doi:10.1016/S0006-3223(01)01291-4
92. Aikens JE, Kroenke K, Nease DE Jr, et al. Trajectories of improvement for six depression-related outcomes. Gen Hosp Psychiatry. 2008;30(1):26-31. PubMed doi:10.1016/j.genhosppsych.2007.10.003
93. Bech P. Social functioning: should it become an endpoint in trials of antidepressants? CNS Drugs. 2005;19(4):313-324. PubMed doi:10.2165/00023210-200519040-00004
94. Weissman MM. Social functioning and the treatment of depression. J Clin Psychiatry. 2000;61(suppl 1):33-38. PubMed
95. Arnow BA, Hunkeler EM, Blasey CM, et al. Comorbid depression, chronic pain, and disability in primary care. Psychosom Med. 2006;68(2):262-268. PubMed doi:10.1097/01.psy.0000204851.15499.fc
96. Breslau N, Lipton RB, Stewart WF, et al. Comorbidity of migraine and depression: investigating potential etiology and prognosis. Neurology. 2003;60(8):1308-1312. PubMed
97. Breslin FC, Gnam W, Franche RL, et al. Depression and activity limitations: examining gender differences in the general population. Soc Psychiatry Psychiatr Epidemiol. 2006;41(8):648-655. PubMed doi:10.1007/s00127-006-0079-6
98. Burton WN, Pransky G, Conti DJ, et al. The association of medical conditions and presenteeism. J Occup Environ Med. 2004;46(suppl 6):S38-S45. PubMed doi:10.1097/01.jom.0000126687.49652.44
99. Carta MG, Hardoy MC, Kovess V, et al. Could health care costs for depression be decreased if the disorder were correctly diagnosed and treated? Soc Psychiatry Psychiatr Epidemiol. 2003;38(9):490-492. PubMed doi:10.1007/s00127-003-0662-z
100. Cramer JA, Blum D, Reed M, et al. Epilepsy Impact Project Group. The influence of comorbid depression on seizure severity. Epilepsia. 2003;44(12):1578-1584. PubMed doi:10.1111/j.0013-9580.2003.28403.x
101. Druss BG, Rosenheck RA. Patterns of health care costs associated with depression and substance abuse in a national sample. Psychiatr Serv. 1999;50(2):214-218. PubMed
102. Egede LE. Diabetes, major depression, and functional disability among US adults. Diabetes Care. 2004;27(2):421-428. PubMed doi:10.2337/diacare.27.2.421
103. Ford JD, Trestman RL, Steinberg K, et al. Prospective association of anxiety, depressive, and addictive disorders with high utilization of primary, specialty and emergency medical care. Soc Sci Med. 2004;58(11):2145-2148. PubMed doi:10.1016/j.socscimed.2003.08.017
104. Frasure-Smith N, Lespérance F, Talajic M. Depression following myocardial infarction: impact on 6-month survival. JAMA. 1993;270(15):1819-1825. PubMed doi:10.1001/jama.270.15.1819
105. Haarasilta L, Marttunen M, Kaprio J, et al. Major depressive episode and physical health in adolescents and young adults: results from a population-based interview survey. Eur J Public Health. 2005;15(5):489-493. PubMed doi:10.1093/eurpub/cki041
106. Hoge CW, Lesikar SE, Guevara R, et al. Mental disorders among US military personnel in the 1990s: association with high levels of health care utilization and early military attrition. Am J Psychiatry. 2002;159(9):1576-1583. PubMed doi:10.1176/appi.ajp.159.9.1576
107. Janssens AC, van Doorn PA, de Boer JB, et al. Anxiety and depression influence the relation between disability status and quality of life in multiple sclerosis. Mult Scler. 2003;9(4):397-403. PubMed doi:10.1191/1352458503ms930oa
108. Keenan-Miller D, Hammen CL, Brennan PA. Health outcomes related to early adolescent depression. J Adolesc Health. 2007;41(3):256-262. PubMed doi:10.1016/j.jadohealth.2007.03.015
109. Kessler RC, Barber C, Birnbaum HG, et al. Depression in the workplace: effects on short-term disability. Health Aff (Millwood). 1999;18(5):163-171. PubMed doi:10.1377/hlthaff.18.5.163
110. Kessler RC, Ormel J, Demler O, et al. Comorbid mental disorders account for the role impairment of commonly occurring chronic physical disorders: results from the National Comorbidity Survey. J Occup Environ Med. 2003;45(12):1257-1266. PubMed doi:10.1097/01.jom.0000100000.70011.bb
111. Kouzis AC, Eaton WW. Emotional disability days: prevalence and predictors. Am J Public Health. 1994;84(8):1304-1307. PubMed doi:10.2105/AJPH.84.8.1304
112. Lerner D, Adler DA, Chang H, et al. The clinical and occupational correlates of work productivity loss among employed patients with depression. J Occup Environ Med. 2004;46(suppl 6):S46-S55. PubMed doi:10.1097/01.jom.0000126684.82825.0a
113. Lespérance F, Frasure-Smith N, Talajic M, et al. Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction. Circulation. 2002;105(9):1049-1053. PubMed doi:10.1161/hc0902.104707
114. Luber MP, Hollenberg JP, Williams-Russo P, et al. Diagnosis, treatment, comorbidity, and resource utilization of depressed patients in a general medical practice. Int J Psychiatry Med. 2000;30(1):1-13. PubMed doi:10.2190/YTRY-E86M-G1VC-LC79
115. McIntyre RS, Wilkins K, Gilmour H, et al. The effect of bipolar I disorder and major depressive disorder on workforce function. Chronic Dis Can. 2008;28(3):84-91. PubMed
116. McQuaid JR, Stein MB, Laffaye C, et al. Depression in a primary care clinic: the prevalence and impact of an unrecognized disorder. J Affect Disord. 1999;55(1):1-10. PubMed doi:10.1016/S0165-0327(98)00191-8
117. Muchmore L, Lynch WD, Gardner HH, et al. Prevalence of arthritis and associated joint disorders in an employed population and the associated healthcare, sick leave, disability, and workers' compensation benefits cost and productivity loss of employers. J Occup Environ Med. 2003;45(4):369-378. PubMed doi:10.1097/01.jom.0000063621.37065.26
118. Martínez-Martín P, Gil-Nagel A, Gracia LM, et al; The Cooperative Multicentric Group. Unified Parkinson's Disease Rating Scale characteristics and structure. Mov Disord. 1994;9(1):76-83. PubMed doi:10.1002/mds.870090112
119. Ginanneschi A, Degl'Innocenti F, Magnolfi S, et al. Evaluation of Parkinson's disease: reliability of three rating scales. Neuroepidemiology. 1988;7(1):38-41. PubMed doi:10.1159/000110159
120. Schwab RS, England AC Jr. Projection technique for evaluating surgery in Parkinson's disease. In: Gillingham FJ, Donaldson MC, eds. Third Symposium of Parkinson's Disease. Edinburgh, Scotland: E&S Livingstone; 1969:152-157.
121. Penninx BW, Beekman AT, Honig A, et al. Depression and cardiac mortality: results from a community-based longitudinal study. Arch Gen Psychiatry. 2001;58(3):221-227. PubMed doi:10.1001/archpsyc.58.3.221
122. Rovner BW. Depression and increased risk of mortality in the nursing home patient. Am J Med. 1993;94(5A):19S-22S PubMed.
123. Rumsfeld JS, Magid DJ, Plomondon ME, et al. History of depression, angina, and quality of life after acute coronary syndromes. Am Heart J. 2003;145(3):493-499. PubMed doi:10.1067/mhj.2003.177
124. Simon GE, VonKorff M, Barlow W. Health care costs of primary care patients with recognized depression. Arch Gen Psychiatry. 1995;52(10):850-856. PubMed
125. Sobocki P, Jönsson B, Angst J, et al. Cost of depression in Europe. J Ment Health Policy Econ. 2006;9(2):87-98. PubMed
126. Sullivan MD, LaCroix AZ, Baum C, et al. Functional status in coronary artery disease: a one-year prospective study of the role of anxiety and depression. Am J Med. 1997;103(5):348-356. PubMed doi:10.1016/S0002-9343(97)00167-8
127. Sullivan MD, LaCroix AZ, Spertus JA, et al. Five-year prospective study of the effects of anxiety and depression in patients with coronary artery disease. Am J Cardiol. 2000;86:1135-1138, A6, A9.
128. Unützer J, Patrick DL, Simon G, et al. Depressive symptoms and the cost of health services in HMO patients aged 65 years and older: a 4-year prospective study. JAMA. 1997;277(20):1618-1623. PubMed doi:10.1001/jama.277.20.1618